What is it about?

Everyone’s body makes one of two major forms of the common cholesterol-related blood protein called haptoglobin. We found that a common cholesterol medication prevented heart disease in people with diabetes who had one haptoglobin form, but people with the other form had no heart disease benefit.

Featured Image

Read the Original

This page is a summary of: Haptoglobin Phenotype Modifies the Effect of Fenofibrate on Risk of Coronary Event: ACCORD Lipid Trial, Diabetes Care, November 2021, American Diabetes Association,
DOI: 10.2337/dc21-1429.
You can read the full text:

Read

Contributors

Be the first to contribute to this page